A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 5,231 shares of ZTS stock, worth $925,677. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,231
Previous 5,480 4.54%
Holding current value
$925,677
Previous $950,000 7.58%
% of portfolio
0.31%
Previous 0.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$172.58 - $196.48 $42,972 - $48,923
-249 Reduced 4.54%
5,231 $1.02 Million
Q2 2024

Jul 05, 2024

BUY
$145.54 - $178.83 $797,559 - $979,988
5,480 New
5,480 $950,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.